
|Videos|September 20, 2016
Hidden Costs for Patients Starting a Specialty Drug Regimen
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.
Advertisement
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Implementing Enfortumab Vedotin-ejfv Plus Pembrolizumab: Navigating Safety Data and the Pharmacist’s Role
2
ACIP Votes to End Universal Hepatitis B Vaccination Recommendation for Infants
3
American Cancer Society Updates Cervical Cancer Screening Guidelines to Include Self-Collection for HPV Testing
4
Closing the Travel Vaccine Gap: How Pharmacists Can Protect Global Travelers
5

















































































































































































































